SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-064353
Filing Date
2024-03-11
Accepted
2024-03-11 08:00:31
Documents
21
Period of Report
2024-03-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d795828d8k.htm   iXBRL 8-K 31757
2 EX-1.1 d795828dex11.htm EX-1.1 176520
3 EX-4.1 d795828dex41.htm EX-4.1 69950
4 EX-5.1 d795828dex51.htm EX-5.1 15955
5 EX-99.1 d795828dex991.htm EX-99.1 11475
9 GRAPHIC g795828g0308073114437.jpg GRAPHIC 2963
10 GRAPHIC g795828g0308101526031.jpg GRAPHIC 1422
11 GRAPHIC g795828g44d35.jpg GRAPHIC 12883
  Complete submission text file 0001193125-24-064353.txt   527408

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20240306.xsd EX-101.SCH 2844
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20240306_lab.xml EX-101.LAB 17235
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20240306_pre.xml EX-101.PRE 10808
22 EXTRACTED XBRL INSTANCE DOCUMENT d795828d8k_htm.xml XML 3500
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 24736578
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)